RZLV.NASDAQRezolve Ai LTD

F-1/A: Rezolve AI Eyes Public Market with Amended F-1 Filing, Registering Shares for Warrant Exercise and Resale

Sentiment:

Registration Statement


Rezolve AI Limited files an amended registration statement to register ordinary shares for potential warrant exercises and resales by selling securityholders.

Capital raiseRezolve has the right to sell to YA up to $250,000,000 Ordinary Shares, subject to certain limitations and conditions set forth in the YA Agreement, from time to time during the term of the YA Agreement.In connection with the amendment and restatement of the YA Agreement, on February 2, 2024, Rezolve Limited and Rezolve issued a convertible note with a total principal amount of $2.5 million (the YA Note) to YA, pursuant to the terms of a convertible promissory note instrument entered into by Rezolve Limited and Rezolve (YA Note Instrument).On September 9, 2024, Rezolve issued YA a promissory note in the principal amount of $5,000,000 (the Additional YA Note), reflecting the first and second tranche of the prepaid advances.In February 2024, certain persons (including Apeiron Investment Group Ltd and certain related parties of Rezolve) entered into subscription agreements (all on substantially the same terms) with Rezolve Limited and Rezolve (Subscription Agreements) to subscribe for convertible promissory notes with a total principal amount of $2,849,906 (the Promissory Notes) in consideration for an advance by each subscriber to Rezolve Limited of an amount equal to 80% of the principal amount subscribed (such amount being the Net Investment Amount).
Worse than expectedThe public warrants are currently out-of-the-money, which means that the trading price of Ordinary Shares underlying the Public Warrants is below the $11.50 exercise price of the Public Warrants.

Summary

  • Rezolve AI Limited has filed an amended registration statement with the SEC.
  • The filing covers the potential issuance of up to 7,499,994 ordinary shares upon exercise of public warrants at $11.50 per share.
  • It also registers the resale of up to 185,068,790 ordinary shares by selling securityholders.
  • These shares include those underlying private warrants, convertible notes, advanced subscription agreements, and agreements with YA II PN, LTD and Northland Securities Inc.
  • The selling holders may have acquired these securities at prices substantially below the current market prices.
  • The company will not receive any proceeds from the sale of ordinary shares by the selling holders, except with respect to amounts received upon exercise of the Warrants to the extent such Warrants are exercised for cash.
  • The company expects to commercialize the Rezolve platform in quarter 4 of 2024, initially in South America with Grupo Carso.
  • Revenues from Brain are also forecast to begin in Q4 2024, increasing significantly in 2025.
  • The company also expects to generate revenues in Q4 2024 in Europe, South America and the Middle East.
  • North American revenues are forecast in Q1 2025.
  • The company expects revenues to increase in Q4 2024 through signed partner agreements with Adobe, ACI, Haendlerbund, Epages, JTL, Oxid and Chatwerk and others by marketing our products to their customer base and are in discussions with significant new partners in markets around the world.

Sentiment

Score: 4

Explanation: The document presents a mixed outlook. While it highlights potential revenue streams and strategic partnerships, it also acknowledges significant risks, including the company's history of losses, dependence on key relationships, and potential market volatility. The out-of-the-money warrants and potential for shareholder dilution further temper the sentiment.

Positives

  • The registration statement allows for potential capital inflow through warrant exercises.
  • The company has secured agreements with several partners to increase revenue in Q4 2024.

Negatives

  • The company will not receive proceeds from the resale of shares by selling holders, except upon cash exercise of warrants.
  • The public warrants are currently out-of-the-money, reducing the likelihood of warrant exercises.
  • Selling securityholders may have acquired their shares at prices substantially below current market prices, potentially leading to volatility.
  • The sale of a substantial number of shares of our Ordinary Shares in the public market, including the number of securities being offered pursuant to this prospectus (which equals approximately 107.48% of the total outstanding Ordinary Shares as of the date of this prospectus, calculated as 185,068,790 Ordinary Shares divided by 172,182,769 currently outstanding Ordinary Shares), or the perception that these sales might occur, could depress the market price of our securities.

Risks

  • The trading price of Ordinary Shares could be volatile, and the value of Ordinary Shares may decline.
  • There can be no assurance that the Public Warrants will ever be in the money at the time they become exercisable or otherwise, and they may expire worthless.
  • A market for our securities may not develop or be sustained, which would adversely affect the liquidity and price of Ordinary Shares.
  • Because Rezolve became a public reporting company by means other than a traditional underwritten initial public offering, the shareholders of Rezolve may face additional risks and uncertainties.
  • If securities or industry analysts publish reports that are interpreted negatively by the investment community or publish negative research reports about our business, our share price and trading volume could decline.
  • We are an emerging growth company, and our election to comply with the reduced disclosure requirements as a public company may make our Ordinary Shares less attractive to investors.
  • We may lose our foreign private issuer status in the future, which could result in significant additional cost and expense.
  • Our issuance of additional Ordinary Shares in connection with financings, acquisitions, investments, our stock incentive plans, or otherwise will dilute all other shareholders.
  • We will incur increased costs as a result of operating as a public company, and our management will be required to devote substantial time to compliance with our public company responsibilities and corporate governance practices.
  • In the event that we do not satisfy the conditions for re-registration as a public limited company by January 9, 2025 we will not be able to effect such re-registration by that date which could impact on the eligibility of our shares for DTC.
  • U.S. holders that directly or indirectly own 10% or more of our equity interests may be subject to adverse U.S. federal income tax consequences under rules applicable to U.S. shareholders of controlled foreign corporations.
  • Our U.S. shareholders may suffer adverse tax consequences if we are classified as a passive foreign investment company.
  • The Internal Revenue Service may not agree that Rezolve should be treated as a non-U.S. corporation for U.S. federal income tax purposes.
  • Section 7874 of the Code may limit the ability of Armada to use certain tax attributes following the Business Combination, increase Rezolves U.S. affiliates U.S. taxable income or have other adverse consequences to Rezolve and Rezolves shareholders.

Future Outlook

Rezolve expects to commercialize its platform in Q4 2024 and anticipates revenue growth through partner agreements and expansion into new markets.

Industry Context

The announcement reflects the ongoing trend of companies in the mobile commerce and AI space seeking public market access to fund growth and development.

Comparison to Industry Standards

  • Comparable companies in the SaaS and AI space often trade at multiples of revenue, making Rezolve's valuation and future performance subject to market sentiment and growth expectations.
  • SPAC mergers have faced increased scrutiny, and Rezolve's success will depend on its ability to execute its business plan and generate sustainable revenue growth.
  • The reliance on key partnerships is a common strategy in the industry, but it also introduces risks related to partner performance and contract renewals.

Stakeholder Impact

  • Shareholders may experience dilution and market volatility.
  • Employees face uncertainty due to the company's financial condition.
  • Customers and partners may be affected by the company's ability to execute its business plan.

Next Steps

  • Commercialize the Rezolve platform in quarter 4 of 2024, initially in South America with Grupo Carso.
  • Generate revenues from Brain are also forecast to begin in Q4 2024, increasing significantly in 2025.
  • Generate revenues in Q4 2024 in Europe, South America and the Middle East.
  • Generate North American revenues are forecast in Q1 2025.
  • Increase revenues in Q4 2024 through signed partner agreements with Adobe, ACI, Haendlerbund, Epages, JTL, Oxid and Chatwerk and others by marketing our products to their customer base and are in discussions with significant new partners in markets around the world.

Key Dates

DateDescription
2021-12-17Rezolve Limited entered into a secured convertible loan note instrument
2022-02-23Rezolve Limited entered into a $250 million standby equity purchase agreement with YA II PN, LTD
2023-02-23Rezolve Limited entered into a $250 million standby equity purchase agreement with YA II PN, LTD
2024-02-02Rezolve Limited and Rezolve issued a convertible note with a total principal amount of $2.5 million (the YA Note) to YA
2024-07-04Rezolve Limited effected the Pre-Closing Demerger
2024-08-15Armada Acquisition Corp. I and Rezolve AI Limited consummated the Business Combination
2024-09-06YA and Rezolve amended and restated the YA Agreement (the Second A&R YA Agreement)
2024-09-09Rezolve issued YA a promissory note in the principal amount of $5,000,000 (the Additional YA Note)
2024-10-28Date of the amended registration statement
2025-01-09Target date for Rezolve AI Limited to re-register as a public limited company

Keywords

ordinary shares, warrants, registration statement, business combination, selling holders, Rezolve AI, Rezolve, securities, SPAC, SEC

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.